Trial Profile
A clinical trial of of VTX 2337 in combination with chemotherapy in patients with metastatic breast cancer.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 24 Jan 2012
Price :
$35
*
At a glance
- Drugs Motolimod (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 24 Jan 2012 New trial record